Lymphoscintigraphy
The nuclear medicine standardRadioactive tracer, an hours-long exam and coarse resolution. Available only in hospital nuclear medicine departments.
Specialized center · ionizing radiationARPA-H LIGHT · University of Arizona
Lymphatic imaging simplified: one injection, one scan. A contrast agent, activated by a dedicated ultrasound pulse sequence, on standard FDA-cleared ultrasound.
VisibleIn minutesAnywhere
The problem
Medicine can image the heart, the brain, the arteries and the veins. The lymphatics have stayed dark. Lymphatic disease is treatable, but diagnosis comes so late that tissue has often scarred into stages nothing can reverse.
The disease is treatable. The delay is what's devastating.
Today's options
Radioactive tracer, an hours-long exam and coarse resolution. Available only in hospital nuclear medicine departments.
Specialized center · ionizing radiationClear images of the first 1–2 cm, but light cannot reach the deep and central lymphatics where clinical decisions are made.
Depth-limited · dedicated camera hardwareDetailed anatomy on scarce magnet time. No functional information, no bedside use, and no practical follow-up cadence.
Capital-intensive · specialized centersProven modalities, confined to centers most patients never reach.
The ILUME procedure
ILUME condenses perfluorobutane (C4F10) microbubbles into liquid nanodroplets small enough to drain into the lymphatics. The imaging pulse turns them back into bright microbubbles only where the probe is looking.
Nanodroplets drain into the lymphatics. They are too small to be trapped and stay stable at body temperature.
The imaging pulse vaporizes the droplets into bright microbubbles exactly where the probe is aimed, inside the lymphatic compartment and not the blood vessels.
Quantitative flow, contractility and anatomy, in minutes, on standard FDA-cleared ultrasound.
Team Arizona
The co-inventor of an FDA-approved ultrasound contrast agent, the inventor of the imaging physics, and the lead author of the field's diagnostic standard, working together for the first time.
Principal Investigator
Professor of Medical Imaging. Inventor of the ultrasound imaging technologies behind ILUME; leads the science.
Co-Principal Investigator
Professor of Surgery. Secretary-General of the International Society of Lymphology and lead author of its lymphedema consensus.
Co-Investigator
Professor of Biomedical Engineering. Co-inventor of Definity, the FDA-approved reference ultrasound contrast agent.
Co-Investigator, Discovery Duo JEDI
Director of the Lymphology-Surgical Biology Laboratory. Builds the disease models and testbeds ILUME is tested on.
Program Development Lead
MedTech executive who has taken multiple device programs from concept through regulatory clearance and exit.
Partner with us
ARPA-H LIGHT funds the science. We are building the partnerships that take ILUME from the lab to the clinic, and we would like to hear from you.
Tell us a little about your organization and what you would like to explore. The program team will reply directly.
Contact the ILUME team